NRD
IART icon

Nebula Research & Development’s Integra LifeSciences IART Stock Holding History

Nebula Research & Development’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-19,030
Closed -$675K – 907
2024
Q1 		$675K Buy
+19,030
New +$761K 0.15% 261

Other funds holding IART

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Nebula Research & Development's IART Position: Q2 2024 in Review

Nebula Research & Development sold out of Integra LifeSciences (IART) in Q2 2024, closing a stake of 19,030 shares — an estimated $675K sold.

Nebula Research & Development first reported a position in IART in Q1 2024 and held it in 1 quarter. The position peaked at $675K in Q1 2024. 238 funds tracked by Wall St. Rank hold IART as of Q2 2024.

  • Nebula Research & Development reported no remaining Integra LifeSciences position as of Q2 2024 after selling out during the quarter.
  • Nebula Research & Development sold 19,030 Integra LifeSciences shares in Q2 2024, an estimated $675K.
  • Nebula Research & Development first reported a position in Integra LifeSciences in Q1 2024 and held it in 1 quarter.
  • Nebula Research & Development's Integra LifeSciences position peaked at $675K in Q1 2024.
  • 238 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2024.

Based on Nebula Research & Development's 13F filing for Q2 2024, filed 14 Aug 2024.